Harerimana Ismail, a community health worker in Kabale District, Uganda, continues to provide critical support to children and adolescents living with HIV despite not receiving a paycheck since early 2025. This situation stems from a significant pause in U.S. foreign aid initiated by the Trump Administration, which halted nearly all aid projects including funding for Ismail’s role at the Kabale Regional Referral Hospital. His salary, previously subsidized by a U.S. grant, was about $50 a month—barely sufficient to sustain himself. Nonetheless, Ismail remains dedicated, visiting homes to ensure that young patients adhere to their medication regimens, while personally navigating the financial challenges of living without an income.
### Impact of U.S. Aid Cuts on Health Services
In January 2025, a decision to suspend U.S. foreign aid led to fears of a substantial decline in global HIV treatment initiatives. Early predictions indicated a potential collapse of HIV/AIDS treatment efforts, with concerns mounting over care disruptions and loss of access to medications for millions. However, recent preliminary data from the U.S. government indicates that treatment levels have remained relatively stable, with a slight decrease of only 100,000 individuals on treatment—a far less dire scenario than initially anticipated.
Jeff Imai-Eaton, an associate professor of epidemiology at Harvard T.H. Chan School of Public Health, noted that while concerns about treatment disruptions were valid, the worst outcomes were largely averted. The resilience of community health workers like Ismail, combined with efforts from local health ministries, played a crucial role in mitigating what could have been a more catastrophic health crisis.
### Resiliency Amidst Aid Disruptions
Community health workers across various regions have displayed remarkable determination in continuing their efforts despite significant obstacles. For Ismail, his personal history of living with HIV motivates him to persist in providing care to young patients. Surviving primarily on homegrown produce, he sells surplus crops to manage his modest living expenses.
Preliminary estimates suggest that treatment coverage in HIV programs supported by the U.S. remains steady. While disruptions initially reported in March 2025 indicated a 23% dip in treatment levels, subsequent analysis revealed that by September of the same year, the decline was largely reversed to just 2%. The U.S. Department of State recently acknowledged this recovery as a result of the concerted efforts made by health authorities and frontline health workers.
### The Challenge of Data Transparency and Aid Quality
The cessation of foreign aid has also impacted the transparency of health data reporting. Historically, the U.S. has been a leader in consistently collecting and disseminating vital statistics related to HIV, providing essential insights that guide policy and allocate resources effectively. However, the suspension of regular data reporting by the U.S. government has raised questions concerning the accuracy of current HIV statistics.
Former Deputy Director of Policy Planning at USAID, Ramona Godbole, highlighted the importance of transparent data sharing, indicating that the absence of updated information creates uncertainty in the ongoing fight against HIV. Although a brief appearance of preliminary data suggested that treatment numbers remained stable, this information was quickly retracted, leaving researchers and advocates seeking clarity on the state of HIV initiatives.
### Future Outlook and Ongoing Concerns
Despite the encouraging news regarding treatment levels, underlying issues persist. Recent statistics show a marked decline in access to essential services such as HIV testing and counseling, which fell from over 80 million individuals to fewer than 70 million within a year. Experts emphasize that, while treatment levels may have stabilized, numerous supportive services have suffered from funding cuts.
Access to preventive measures, including condoms, has also diminished, impacting vulnerable populations. Ismail pointed out concerns regarding medication supply and the dire conditions faced by patients, noting that extended wait times at health facilities often average between four and nine hours.
Reflecting on the broader implications of these trends, Emily Bass, an author and expert on HIV policy, expressed concern that the ongoing changes in U.S. support raise fundamental questions regarding the adequacy of care provided to those affected by HIV/AIDS. The combination of reduced resources and challenges in data transparency could lead not only to accessibility issues but also catalyze adverse health outcomes.
The situation remains precarious for Ismail and many other community health workers dedicated to HIV care. While their unwavering commitment offers a glimmer of hope for patients, the sustainability of such efforts without reasonable compensation raises valid concerns about the long-term efficacy of HIV/AIDS programs in light of the ongoing disruptions in foreign aid. As health authorities work to navigate these challenges, the critical role of community workers like Ismail will undoubtedly remain vital in promoting adherence to treatment and ensuring that vulnerable populations receive the support they need.
Source reference: Full report
About The Author
